China Resources Pharmaceutical Completes Green Cross HK Acquisition
Company Announcements

China Resources Pharmaceutical Completes Green Cross HK Acquisition

China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.

China Resources Pharmaceutical Group Ltd. has successfully completed the acquisition of Green Cross HK, marking a significant expansion for its subsidiary, CR Boya Bio-pharmaceutical. The acquisition, now finalized, positions Green Cross HK as a wholly-owned subsidiary of CR Boya Bio-pharmaceutical, enhancing the group’s footprint in the biopharmaceutical sector.

For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskChina Resources Subsidiary Reports Revenue Surge Amid Cash Challenges
TipRanks HongKong Auto-Generated NewsdeskChina Resources Sanjiu Reports Rising Profits Despite Cash Decline
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App